致动脉粥样硬化性血脂异常与卒中或TIA后残余血管风险
本研究为前瞻性观察性研究,连续纳入792例急性缺血性卒中或TIA患者,随访1年。致动脉粥样硬化性血脂异常(AD)定义为空腹甘油三酯≥150 mg/dL且男性HDL-C<40 mg/dL或女性<50 mg/dL。AD患病率12.2%,与颅内动脉狭窄相关,并增加主要不良心血管事件和缺血性卒中风险。
要点
- AD患者1年主要不良心血管事件年发生率为24.5%,无AD者为10.6%。
- AD增加主要不良心血管事件风险(HR 2.33,95%CI 1.44-3.80)。
- AD在LDL-C≥100和<100 mg/dL亚组中均预测主要不良心血管事件。
核心结论
- AD与颅内动脉粥样硬化及卒中或TIA后高残余血管风险相关,是二级预防的可干预靶点。
研究设计与样本
- 前瞻性观察性研究,连续纳入792例急性缺血性卒中(n=710)或TIA(n=82)患者,平均年龄70.1岁,男性60.2%,随访1年。
主要发现
- AD患病率为12.2%。
- AD患者颅内动脉狭窄发生率高于无AD者(42.3% vs 24.1%,P=0.004)。
- AD患者1年主要不良心血管事件年发生率为24.5% vs 10.6%(HR 2.33,95%CI 1.44-3.80)。
- AD患者1年缺血性卒中发生率更高(16.8% vs 8.6%,HR 1.84,95%CI 1.04-3.26)。
- 在LDL-C≥100 mg/dL亚组(n=509),AD预测主要不良心血管事件(年发生率20.5% vs 9.6%,P=0.036)。
关键数值与推荐
- AD定义:空腹甘油三酯≥150 mg/dL且男性HDL-C<40 mg/dL或女性<50 mg/dL。
- 主要结局:非致死性卒中、非致死性急性冠脉综合征和血管性死亡的复合终点。
临床怎么用
- 对卒中或TIA患者应评估AD,以识别残余血管风险较高的个体。
- AD可作为二级预防的可干预靶点,但具体干预策略需进一步研究。
局限性
- 本研究为观察性研究,不能确定因果关系。
- 样本来自单中心或特定人群,外推性需谨慎。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND PURPOSE: Notwithstanding the current guideline-based management, patients with stroke retain a substantial risk of further vascular events. We aimed to assess the contribution of atherogenic dyslipidemia (AD) to this residual risk. METHODS: This was a prospective observational study, in which 792 patients (mean age, 70.1 years; male, 60.2%) with acute ischemic stroke (n=710) or transient ischemic attack (n=82) within 1 week of onset were consecutively enrolled and followed for 1 year. AD was defined as having both elevated levels of triglycerides ≥150 mg/dL and low HDL-C (high-density lipoprotein cholesterol) <40 mg/dL in men or <50 mg/dL in women, under fasting conditions. The primary outcome was a composite of major adverse cardiovascular events, including nonfatal stroke, nonfatal acute coronary syndrome, and vascular death. RESULTS: The prevalence of AD was 12.2%. Patients with AD more often had intracranial artery stenosis than those without (42.3% versus 24.1%; P=0.004), whereas no differences were observed in the prevalence of extracranial artery stenosis (17.7% versus 12.9%; P=0.62) or aortic plaques (33.3% versus 27.0%; P=0.87). At 1 year, patients with AD were at a greater risk of major adverse cardiovascular events (annual rate, 24.5% versus 10.6%; hazard ratio [95% CI], 2.33 [1.44-3.80]) and ischemic stroke (annual rate, 16.8% versus 8.6%; hazard ratio [95% CI], 1.84 [1.04-3.26]) than those without AD. When patients were stratified according to baseline LDL-C (low-density lipoprotein cholesterol) level, AD was predictive of major adverse cardiovascular events among those with LDL-C ≥100 mg/dL (n=509; annual rate, 20.5% versus 9.6%; P=0.036) as well as those with LDL-C <100 mg/dL (n=283; annual rate, 38.6% versus 12.4%; P<0.001). CONCLUSIONS: AD is associated with intracranial artery atherosclerosis and a high residual vascular risk after a stroke or transient ischemic attack. AD should be a promising modifiable target for secondary stroke prevention. Registration: URL: https://upload.umin.ac.jp; Unique identifier: UMIN000031913.
引用
- Hoshino T, Ishizuka K, Toi S, et al. Atherogenic Dyslipidemia and Residual Vascular Risk After Stroke or Transient Ischemic Attack. Stroke. 2021. PMID: 34470483. doi:10.1161/STROKEAHA.121.034593
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。